Implantable Cardioverter Defibrillator Market Size, Share and Trends Analysis | Global | 2025-2032 | MedCore | Includes: Transvenous ICD, Subcutaneous ICD, and Extravascular ICDs

Year: 2026
Scope: 10 Years
Region: Global
Published Date: 12/31/2025
Type: MedCore

Product Description

The global ICD market was valued at over $3.1 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.0% to reach $4.08 billion by 2035.

The full report suite on the global market for implantable cardioverter defibrillators (ICDs) includes single-chamber ICDs, dual-chamber ICDs, subcutaneous ICDs (S-ICDs) and extra-vascular ICDs (EV-ICDs).

The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

Data Types Included

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2032, and Historical Data to 2022
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

Implantable Cardioverter Defibrillator Market Trends

The implantable cardioverter defibrillator market has returned to a stable growth profile supported by consistent guideline reinforcement for primary and secondary prevention and by an expanding population of patients with structural heart disease. Unit volume remains steady across major regions as physicians continue to rely on ICDs for long-term protection against sudden cardiac death.

Implantable Cardioverter Defibrillator Market Share Insights

Top Global Implantable Cardioverter Defibrillator Market Share Leaders

Boston Scientific is the global leader in the ICD market, supported by a comprehensive high-voltage portfolio and the most established subcutaneous ICD platform. The company’s competitive advantage is anchored by its leadership in subcutaneous ICD therapy. The Emblem MRI™ system remains the only widely adopted subcutaneous ICD on the market with extensive global clinical validation. Its transvenous lineup includes Dynagen™, Dynagen™ Mini, Inogen™ and Inogen™ Mini, which offer compact form factors, extended device longevity and advanced arrhythmia detection. These systems are widely used across primary and secondary prevention indications and continue to hold solid share in major markets.
Medtronic holds the second-leading position in the ICD market with a broad and consistently updated portfolio. Its current platforms, including Cobalt™, Crome™, Evera MRI™ and Visia AF MRI™, provide strong coverage across transvenous markets with remote monitoring technological advances. The launch of the Aurora EV ICD™ extravascular ICD has reinforced Medtronic’s position by offering a less invasive alternative to traditional ICD systems with pacing capability preserved. They also offer antitachycardia pacing, offering a unique advantage over the already-penetrated subcutaneous ICDs offered currently. Medtronic’s scale, global distribution and extensive clinical evidence continue to support its leadership in this market.
Abbott holds a stable third position in the global ICD market, supported by a streamlined and modern portfolio. Its high-voltage lineup is anchored by Gallant™, which offers extended longevity, advanced diagnostics and Bluetooth-enabled remote monitoring. Entrant™ provides a cost-efficient option for value-driven markets, while Ellipse™ maintains continued use in regions with established familiarity. Recent enhancements in battery performance, sensing algorithms and digital follow-up through the myMerlinPulse platform have strengthened Abbott’s competitiveness in the transvenous segment. Although the company does not offer subcutaneous or extra vascular ICD systems, it remains well positioned through device reliability, compact design and integration with its broader cardiac rhythm management portfolio.

Implantable Cardioverter Defibrillator Market Segmentation Summary

Transvenous ICD Market – Further Segmented Into:
- Placement Type: Initial Placement and Replacement.
Subcutaneous ICD Market – Further Segmented Into:
- Placement Type: Initial Placement and Replacement.
Extravascular ICD Market

Research Scope Summary

Report Attribute	Details
Regions	North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year	2025
Forecast	2026-2032
Historical Data	2022-2024
Quantitative Coverage	Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage	Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources	Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

List Of Figures

List Of Charts

Research Methodology

Step 1: Project Initiation & Team Selection

Step 2: Prepare Data Systems And Perform Secondary Research

Step 3: Preparation For Interviews & Questionnaire Design

Step 4: Performing Primary Research

Step 5: Research Analysis: Establishing Baseline Estimates

Step 6: Market Forecast And Analysis

Step 7: Identify Strategic Opportunities

Step 8: Final Review And Market Release

Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Implantable Cardioverter Defibrillator Market

Executive Summary

5.1.1 Global Implantable Cardioverter Defibrillator Market Overview

5.1.2 Competitive Analysis

5.1.3 Procedure Segmentation

5.1.4 Market Segmentation

5.1.5 Regions Included

Introduction

Procedure Numbers

5.1.6 Total Icd Placement Procedures

5.1.7 Initial Placement Icd Procedures

5.1.8 Replacement Icd Procedures

Market Overview

5.1.9 By Segment

5.1.1 By Region

Market Analysis And Forecast

5.1.2 Total Icd Market

5.1.1 Single-Chamber Icd Market

5.1.1.1 Initial Placement Single-Chamber Icd Market

5.1.1.2 Replacement Single-Chamber Icd Market

5.1.1 Dual-Chamber Icd Market

5.1.1.1 Initial Placement Dual-Chamber Icd Market

5.1.1.2 Replacement Dual-Chamber Icd Market

5.1.1 S-Icd Market

5.1.1.1 Initial Placement S-Icd Market

5.1.1.2 Replacement S-Icd Market

5.1.2 Ev-Icd Market

Drivers And Limiters

5.1.3 Market Drivers

5.1.4 Market Limiters

Competitive Market Share Analysis

Abbreviations

Companies Included

· Abbott	· Kardium
· Acutus Medical	· Lepu Medical
· Adagio	· Medico S.p.A
· AtriCure	· Medtronic
· Avertix Medical	· MicroPort
· Biotronik	· Oskor
· Boston Scientific	· Osypka AG
· CathRx	· Philips
· CathVision	· Schwarzer Cardiotek
· GE Healthcare	· Shree Pacetronix
· Imricor Medical Systems	· Siemens
· Innovative Health	· Stereotaxis
· Integra	· Vectorius
· JJET	· Vitatron
· Johnson & Johnson	· ZOLL

Chart List

Chart 5‑1: Implantable Cardioverter Defibrillator Market, Global, 2025 & 2032

Chart 5‑2: Implantable Cardioverter Defibrillator Placement Procedures, Global, 2025

Chart 5‑3: ICD Placement Procedures by Segment, Global, 2022 – 2032

Chart 5‑4: ICD Market by Segment, Global, 2022 – 2032

Chart 5‑5: ICD Market by Region, Global, 2022 – 2032

Chart 5‑6: Leading Competitors, ICD Market, Global, 2025

Figure List

Figure 5‑1: Implantable Cardioverter Defibrillator Procedure Segmentation

Figure 5‑2: Implantable Cardioverter Defibrillator Market Segmentation

Figure 5‑3: Implantable Cardioverter Defibrillator Regions Covered, Global (1 of 2)

Figure 5‑4: Inferior Vena Cava Filter Regions Covered, Global (2 of 2)

Figure 5‑5: ICD Placement Procedures by Segment, Global, 2022 – 2032

Figure 5‑6: ICD Placement Procedures by Region, Global, 2022 – 2032

Figure 5‑7: ICD Placement Procedures by Country, North America, 2022 – 2032

Figure 5‑8: ICD Placement Procedures by Country, Latin America, 2022 – 2032 (1 of 2)

Figure 5‑9: ICD Placement Procedures by Country, Latin America, 2022 – 2032 (2 of 2)

Figure 5‑10: ICD Placement Procedures by Country, Western Europe, 2022 – 2032

Figure 5‑11: ICD Placement Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)

Figure 5‑12: ICD Placement Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)

Figure 5‑13: ICD Placement Procedures by Country, Middle East, 2022 – 2032

Figure 5‑14: ICD Placement Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)

Figure 5‑15: ICD Placement Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)

Figure 5‑16: ICD Placement Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)

Figure 5‑17: ICD Placement Procedures by Country, Africa, 2022 – 2032

Figure 5‑18: Initial Placement ICD Procedures by Region, Global, 2022 – 2032

Figure 5‑19: Initial Placement ICD Procedures by Country, North America, 2022 – 2032

Figure 5‑20: Initial Placement ICD Procedures by Country, Latin America, 2022 – 2032 (1 of 2)

Figure 5‑21: Initial Placement ICD Procedures by Country, Latin America, 2022 – 2032 (2 of 2)

Figure 5‑22: Initial Placement ICD Procedures by Country, Western Europe, 2022 – 2032

Figure 5‑23: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)

Figure 5‑24: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)

Figure 5‑25: Initial Placement ICD Procedures by Country, Middle East, 2022 – 2032

Figure 5‑26: Initial Placement ICD Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)

Figure 5‑27: Initial Placement ICD Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)

Figure 5‑28: Initial Placement ICD Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)

Figure 5‑29: Initial Placement ICD Procedures by Country, Africa, 2022 – 2032

Figure 5‑30: Replacement ICD Procedures by Region, Global, 2022 – 2032

Figure 5‑31: Replacement ICD Procedures by Country, North America, 2022 – 2032

Figure 5‑32: Replacement ICD Procedures by Country, Latin America, 2022 – 2032 (1 of 2)

Figure 5‑33: Replacement ICD Procedures by Country, Latin America, 2022 – 2032 (2 of 2)

Figure 5‑34: Replacement ICD Procedures by Country, Western Europe, 2022 – 2032

Figure 5‑35: Replacement ICD Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)

Figure 5‑36: Replacement ICD Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)

Figure 5‑37: Replacement ICD Procedures by Country, Middle East, 2022 – 2032

Figure 5‑38: Replacement ICD Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)

Figure 5‑39: Replacement ICD Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)

Figure 5‑40: Replacement ICD Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)

Figure 5‑41: Replacement ICD Procedures by Country, Africa, 2022 – 2032

Figure 5‑42: ICD Market by Segment, Global, 2022 – 2032 (US$M)

Figure 5‑43: ICD Market by Region, Global, 2022 – 2032 (US$M)

Figure 5‑44: ICD Market, Global, 2022 – 2032

Figure 5‑45: Units Sold by Region, ICD Market, Global, 2022 – 2032

Figure 5‑46: Average Selling Price by Region, ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑47: Market Value by Region, ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑48: Single-Chamber ICD Market by Segment, Global, 2022 – 2032 (US$M)

Figure 5‑49: Single-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑50: Units Sold by Region, Single-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑51: Average Selling Price by Region, Single-Chamber ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑52: Market Value by Region, Single-Chamber ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑53: Initial Placement Single-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑54: Units Sold by Region, Initial Placement Single-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑55: Average Selling Price by Region, Initial Placement Single-Chamber ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑56: Market Value by Region, Initial Placement Single-Chamber ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑57: Replacement Single-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑58: Units Sold by Region, Replacement Single-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑59: Average Selling Price by Region, Replacement Single-Chamber ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑60: Market Value by Region, Replacement Single-Chamber ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑61: Dual-Chamber ICD Market by Segment, Global, 2022 – 2032 (US$M)

Figure 5‑62: Dual-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑63: Units Sold by Region, Dual-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑64: Average Selling Price by Region, Dual-Chamber ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑65: Market Value by Region, Dual-Chamber ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑66: Initial Placement Dual-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑67: Units Sold by Region, Initial Placement Dual-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑68: Average Selling Price by Region, Initial Placement Dual-Chamber ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑69: Market Value by Region, Initial Placement Dual-Chamber ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑70: Replacement Dual-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑71: Units Sold by Region, Replacement Dual-Chamber ICD Market, Global, 2022 – 2032

Figure 5‑72: Average Selling Price by Region, Replacement Dual-Chamber ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑73: Market Value by Region, Replacement Dual-Chamber ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑74: S-ICD Market by Segment, Global, 2022 – 2032 (US$M)

Figure 5‑75: S-ICD Market, Global, 2022 – 2032

Figure 5‑76: Units Sold by Region, S-ICD Market, Global, 2022 – 2032

Figure 5‑77: Average Selling Price by Region, S-ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑78: Market Value by Region, S-ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑79: Initial Placement S-ICD Market, Global, 2022 – 2032

Figure 5‑80: Units Sold by Region, Initial Placement S-ICD Market, Global, 2022 – 2032

Figure 5‑81: Average Selling Price by Region, Initial Placement S-ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑82: Market Value by Region, Initial Placement S-ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑83: Replacement S-ICD Market, Global, 2022 – 2032

Figure 5‑84: Units Sold by Region, Replacement S-ICD Market, Global, 2022 – 2032

Figure 5‑85: Average Selling Price by Region, Replacement S-ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑86: Market Value by Region, Replacement S-ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑87: EV-ICD Market, Global, 2022 – 2032

Figure 5‑88: Units Sold by Region, EV-ICD Market, Global, 2022 – 2032

Figure 5‑89: Average Selling Price by Region, EV-ICD Market, Global, 2022 – 2032 (US$)

Figure 5‑90: Market Value by Region, EV-ICD Market, Global, 2022 – 2032 (US$M)

Figure 5‑91: Leading Competitors, ICD Market, Global, 2025

Figure 5‑92: Leading Competitors by Region, ICD Market, Global, 2025

Figure 5‑93: Leading Competitors by Region, Single-Chamber ICD Market, Global, 2025

Figure 5‑94: Leading Competitors by Region, Dual-Chamber ICD Market, Global, 2025

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

Report Summary

FREE

Select License Type

The full report suite on the global market for cardiac resynchronization therapy (CRT) devices includes cardiac resynchronization therapy-pacemakers (CRT-Ps) and cardiac resynchronization therapy-defibrillators (CRT-Ds).